Funder
GlaxoSmithKline Biologicals SA
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference35 articles.
1. Strifler L, Morris SK, Dang V, Tu HA, Minhas RS, Jamieson FB, et al. The health burden of invasive meningococcal disease: a systematic review. J Pediatric Infec Dis Soc. 2016;5:417–30.
https://doi.org/10.1093/jpids/piv065
.
2. Al-Janabi H, Van Exel J, Brouwer W, Trotter C, Glennie L, Hannigan L, et al. Measuring health spillovers for economic evaluation: a case study in meningitis. Health Econ. 2016;25:1529–44.
https://doi.org/10.1002/hec.3259
.
3. Bhadhuri A, Jowett S, Jolly K, Al-Janabi H. A comparison of the validity and responsiveness of the EQ-5D-5L and SF-6D for measuring health spillovers: a study of the family impact of meningitis. Med Decis Mak. 2017;37:882–93.
https://doi.org/10.1177/0272989X17706355
.
4. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report for 2016 - Invasive meningococcal disease. 2016. Available from:
https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2016-invasive-meningococcal-disease_1.pdf
. Accessed 29 Mar 2019.
5. World Health Organization (WHO). Meningococcal meningitis - Key facts. 2018. Available from:
http://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis
. Accessed 17 Sept 2018.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献